Cytomegalovirus (CMV) Clinical Trials in Guangzhou, Guangdong
2 recruitingGuangzhou, Guangdong, China
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)
Cytomegalovirus (CMV)
Takeda80 enrolled53 locationsNCT05319353
Recruiting
Phase 3
A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections
Cytomegalovirus (CMV)
Takeda20 enrolled12 locationsNCT06439342